TrialBlood2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Ariela Noy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this paperpooled itcites it
TrialBlood2015
Ariela Noy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.